Evidence map›Paper›PMID 38067518›Full record

ArticleMolecules (Basel, Switzerland)2023

Tetrahydrocurcumin Derivatives Enhanced the Anti-Inflammatory Activity of Curcumin: Synthesis, Biological Evaluation, and Structure-Activity Relationship Analysis.

Yisett González, Randy Mojica-Flores, Dilan Moreno-Labrador, Marisín Pecchio, K S Jagannatha Rao, Maicol Ahumedo-Monterrosa, Patricia L Fernández, Oleg V Larionov, Johant Lakey-Beitia

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Yisett GonzálezCenter for Molecular and Cellular Biology of Diseases, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama.ORCID 0000-0002-1623-9484
Randy Mojica-FloresCenter for Biodiversity and Drug Discovery, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama.ORCID 0000-0003-4514-3083
Dilan Moreno-LabradorCenter for Molecular and Cellular Biology of Diseases, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama.ORCID 0000-0001-9233-8583
Marisín PecchioCenter for Academic Affairs and Collaboration, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama.ORCID 0000-0002-4125-1661
K S Jagannatha RaoDepartment of Biotechnology, Koneru Lakshmaiah Education Foundation (KLEF) Deemed to be University, Vaddeswaram 522 302, India.ORCID 0000-0003-4290-7666
Maicol Ahumedo-MonterrosaNatural Products Group, School of Pharmaceutical Sciences, Zaragocilla Campus, University of Cartagena, Cartagena 130015, Colombia.ORCID 0000-0002-1805-3261
Patricia L FernándezCenter for Molecular and Cellular Biology of Diseases, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama.ORCID 0000-0002-0762-0566
Oleg V LarionovDepartment of Chemistry, The University of Texas at San Antonio, San Antonio, TX 78249, USA.ORCID 0000-0002-3026-1135
Johant Lakey-BeitiaSistema Nacional de Investigación (SNI), SENACYT, Panama City 0816-02852, Panama.ORCID 0000-0001-7554-4043
Instituto de Investigaciones Científicas y Servicios de Alta Tecnología · PASecretaría Nacional de Ciencia, Tecnología e Innovación · PAKoneru Lakshmaiah Education Foundation · INThe University of Texas at San Antonio · USUniversity of Cartagena · CO

Funding

INDICASAT AIP JR04-2020Secretaría Nacional de Ciencia, Tecnología e Innovación FID17-002Secretaría Nacional de Ciencia, Tecnología e Innovación FID23-003Secretaría Nacional de Ciencia, Tecnología e Innovación ITE18-R1-006Welch Foundation AX-0047
6 · The paper itself

Abstract

Tetrahydrocurcumin, the most abundant curcumin transformation product in biological systems, can potentially be a new alternative therapeutic agent with improved anti-inflammatory activity and higher bioavailability than curcumin. In this article, we describe the synthesis and evaluation of the anti-inflammatory activities of tetrahydrocurcumin derivatives. Eleven tetrahydrocurcumin derivatives were synthesized via Steglich esterification on both sides of the phenolic rings of tetrahydrocurcumin with the aim of improving the anti-inflammatory activity of this compound. We showed that tetrahydrocurcumin (

Indexed as

CurcuminAnti-Inflammatory AgentsInterleukin-6Structure-Activity RelationshipTumor Necrosis Factor-alphaAnti-Inflammatory AgentsCurcuminInterleukin-6tetrahydrocurcuminTumor Necrosis Factor-alpha3D-QSARanti-inflammatory activitycurcumincytokineIL-6PGE2structure–activity relationshipsuccinatetetrahydrocurcumintetrahydrocurcumin derivativesTNF-α

Identifiers

PMID38067518
PMCPMC10708537
OpenAlexW4389056890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.